Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Neoplasms 4Breast Neoplasms 4Liver Neoplasms 2Esophageal Neoplasms 2Stage IA Uterine Sarcoma 1Prostate Cancer With Intermediate Risk 1Glioblastoma 1Endometrial Adenocarcinoma 1Deglutition Disorders 1Cholangiocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

Tamoxifen 3Mastectomy, Segmental 2Immunohistochemistry 2talimogene laherparepvec 1abemaciclib 1Surgical Procedures, Operative 1Sugars 1Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Naltrexone 1Mass Spectrometry 1Lovastatin 1Ipilimumab 1Infliximab 1Hypericum extract LI 160 1Genotype 1Gels 1Gefitinib 1Fluorescent Antibody Technique 1Flow Cytometry 1Chromatography, Liquid 1Chemotherapy, Adjuvant 1Celecoxib 1CTLA-4 Antigen 1Brachytherapy 1Biopsy, Needle 1Biopsy, Fine-Needle 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Carcinoma In Situ × Brachytherapy × Clear all
NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
45 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡